Usefulness of the maintenance of wakefulness test in central disorders of hypersomnolence: a scoping review.

driving fitness excessive daytime sleepiness hypersomnia maintenance of wakefulness test motivation narcolepsy

Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
11 08 2022
Historique:
received: 01 02 2022
revised: 08 04 2022
pubmed: 17 4 2022
medline: 13 8 2022
entrez: 16 4 2022
Statut: ppublish

Résumé

To review the Maintenance of Wakefulness Test (MWT) as assessment of daytime sleepiness in the evaluation of treatment effects and driving fitness in central disorders of hypersomnolence (CDH). We performed a scoping review of studies using the MWT in patients with CDH (i.e. narcolepsy types 1 and 2, and idiopathic hypersomnia). N = 20 articles were included, comprising 683 patients and 129 controls. MWT effect sizes were compared to the Clinical Global Impression (GCI) scale and the Epworth Sleepiness Scale (ESS). MWT sleep latency was correlated to objective driving performances. The role of motivation was evaluated by comparing MWTs of treatment studies (low motivation) to driving fitness studies (high motivation to stay awake). Healthy controls were compared to norm values. MWT and CGI were both impacted by the same treatment; however, the MWT has higher effect sizes and was more sensitive to measure these effects. The MWT correlated fairly to moderately (ρ = -0.26 to -0.56; p ≤ .05) to objective driving performance. Motivation played a major role on MWT sleep latencies (d = 0.76 to 1.43; p ≤ .001). Current norm values may not be valid, as sleep latency may be impacted by age. The MWTs applicability to measure treatment effects in CDH was confirmed, but age-adjusted norm values are needed. For a more complete evaluation of EDS it should be combined with subjective measures. Its reliability for driving fitness evaluation is insufficient, and motivation plays a major role. To predict or monitor driving performance in CDH, valid and easy methods should be developed.

Identifiants

pubmed: 35429267
pii: 6569231
doi: 10.1093/sleep/zsac091
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Denise Bijlenga (D)

Stichting Epilepsie Instellingen Nederland, Sleep-Wake Center, Heemstede, The Netherlands.
Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.

Sebastiaan Overeem (S)

Centre for Sleep Medicine, Kempenhaeghe, Heeze, The Netherlands.
Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.

Rolf Fronczek (R)

Stichting Epilepsie Instellingen Nederland, Sleep-Wake Center, Heemstede, The Netherlands.
Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.

Gert Jan Lammers (GJ)

Stichting Epilepsie Instellingen Nederland, Sleep-Wake Center, Heemstede, The Netherlands.
Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH